𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

✍ Scribed by Metcalfe, K; Gershman, S; Lynch, H T; Ghadirian, P; Tung, N; Kim-Sing, C; Olopade, O I; Domchek, S; McLennan, J; Eisen, A

Book ID
109838745
Publisher
Nature Publishing Group
Year
2011
Tongue
English
Weight
345 KB
Volume
104
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tamoxifen and contralateral breast cance
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: An update
✍ Jacek Gronwald; Nadine Tung; William D. Foulkes; Kenneth Offit; Ruth Gershoni; M πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 77 KB

## Abstract Women with a mutation in __BRCA1__ or __BRCA2__ face a lifetime risk of breast cancer of ∼80%, and following the first diagnosis the10‐year risk of contralateral breast cancer is ∼30%. It has been shown that both tamoxifen and oophorectomy prevent contralateral breast cancer, but it is

Coffee consumption and breast cancer ris
Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers
✍ AndrΓ© Nkondjock; Parviz Ghadirian; Joanne Kotsopoulos; Jan Lubinski; Henry Lynch πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 91 KB πŸ‘ 1 views

## Abstract Although there are several plausible biologic mechanisms whereby coffee consumption might influence the risk of breast cancer, epidemiologic evidence is limited. We assessed the association between coffee consumption and breast cancer risk among high‐risk women who carry __BRCA__ mutati